ClinicalTrials.Veeva

Menu

Assessing the Effect of Abstinence Period on Semen Parameters

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status

Withdrawn

Conditions

Infertility, Male

Treatments

Other: Abstinence followed by semen sample collection.

Study type

Interventional

Funder types

Other

Identifiers

NCT05701163
21-10024093

Details and patient eligibility

About

The goal of this study is to learn about the impact of abstinence periods on sperm quality in healthy males 20-45 years of age with no significant comorbidities who are able to produce a semen sample via masturbation. The main question it aims to answer is:

• Do shorter abstinence periods result in improved semen quality?

Participants will provide semen samples for analysis following abstinence periods of 7 days, 5 days, 2 days, 1 day, and 3 hours.

Full description

Participant Duration: Total length of time on study per subject is 14 days (including 5 days of visit required for sample production). Subjects do not need to complete the visits in order but need to document abstinence period prior to sample production. No follow up will be needed after the study.

Primary Objective: The primary objective is to examine the differences in semen analysis parameters after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

Secondary Objectives: The secondary objective(s) is to assess changes in sperm DNA fragmentation after varying abstinence periods (7 days, 5 days, 2 days, 1 day, 3 hours).

Sex

Male

Ages

20 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Males, aged 20-45 years
  • Healthy, no significant comorbidities
  • Able to produce a semen sample by masturbation
  • Total sperm count ≥ 1 million sperm
  • Abnormal sperm DNA fragmentation (TUNEL assay value ≥ 20%)

Exclusion criteria

  • Age < 20 or > 45 years
  • Significant comorbidities, including significant cardiac, pulmonary, gastrointestinal, hematologic, or neurologic disease
  • Total sperm count < 1 million sperm
  • Aspermia (semen volume = 0)
  • Normal sperm DNA fragmentation (TUNEL assay value < 20%)

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Healthy Volunteers
Experimental group
Description:
Healthy males with no significant comorbidities, aged 20-45 years who are able to produce a semen sample by masturbation.
Treatment:
Other: Abstinence followed by semen sample collection.

Trial contacts and locations

1

Loading...

Central trial contact

Grace Tan, MA; Akeem Noziere

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems